机构:[1]Department of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Tongfu Middle Road, Haizhu District, Guangzhou 510220, Guangdong, People’s Republic of China[2]Department of Orthopedics, Huizhou First Hospital, Huizhou 516003, Guangdong, People’s Republic of China[3]Department of Oncology, Huizhou Hospital of Guangzhou University of Traditional Chinese Medicine, Huizhou 516001, Guangdong, People’s Republic of China[4]Department of Orthopedics, Huizhou Central People’s Hospital, Huizhou 516008, Guangdong, People’s Republic of China
Ethics Committee
of Guangzhou Red Cross Hospital Affiliated to Jinan University
(approval number: 20181205).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|3 区医学
小类|4 区肿瘤学
最新[2025]版:
大类|3 区医学
小类|4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Tongfu Middle Road, Haizhu District, Guangzhou 510220, Guangdong, People’s Republic of China[2]Department of Orthopedics, Huizhou First Hospital, Huizhou 516003, Guangdong, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
Wang Bin,Yan Lifang,Shi Weihong,et al.CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis.[J].International journal of clinical oncology.2022,27(4):811-822.doi:10.1007/s10147-022-02122-y.
APA:
Wang Bin,Yan Lifang,Shi Weihong,Xie Han,Chen Ruixiong...&Liang Weiguo.(2022).CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis..International journal of clinical oncology,27,(4)
MLA:
Wang Bin,et al."CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis.".International journal of clinical oncology 27..4(2022):811-822